| Biomarker ID | 1254 |
| PMID | 24292680 |
| Year | 2013 |
| Biomarker | Forkhead Box A1 [FOXA1] |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Increased in shorter time to Biochemical Recurrence |
| Odds Ratio/Hazard Ratio/Relative Risk | HR: 5.0 (95% CI: 1.2–21.1) |
| Effect on Pathways | Pathways include: HNF3A pathway, HNF3B pathway, p53 signaling pathway |
| Experiment | Biochemical recurrence Vs No Biochemical Recurrence |
| Type of Biomarker | Prognostic |
| Cohort | 102 prostate cancer patients were chosen for the study, out of which 26 had low FOXA1 H score and 76 had high FOXA1 H score |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p = 0.028 |
| Method Used | Tissue Microarray |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |